ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,464Medicare Part D Prescriptions Filled, Including Refills

Rank: 111 out of 2588

$1.02M Total Retail Price of All Prescriptions

Rank: 84 out of 2588

794 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 794 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

15% of this provider’s 794 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 12,469 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 792 634 1 1
LEVOTHYROXINE SODIUM 554 469 2 2
AMLODIPINE BESYLATE 502 440 3 4
FUROSEMIDE 483 348 4 5
LISINOPRIL 446 352 5 3
HYDROCODONE-ACETAMINOPHEN 424 230 S3 6 7
OMEPRAZOLE 408 322 7 6
WARFARIN SODIUM 324 282 8 10
MELOXICAM 284 257 9 51
CARVEDILOL 279 212 10 20
METFORMIN HCL 266 220 11 8
TRIAMTERENE-HCTZ 255 219 12 46
RANITIDINE HCL 250 189 13 37
POTASSIUM CHLORIDE 231 186 14 15
METOPROLOL SUCCINATE 223 177 15 12
ATENOLOL 219 186 16 14
GABAPENTIN 183 118 17 18
METOPROLOL TARTRATE 177 132 18 9
GLYBURIDE 170 147 R 19 65
DONEPEZIL HCL 170 170 19 22
DOXAZOSIN MESYLATE 168 160 21 96
ALENDRONATE SODIUM 157 150 22 21
AZITHROMYCIN 156 119 23 45
HYDROCHLOROTHIAZIDE 152 143 24 13
DIVALPROEX SODIUM 152 115 24 89
ATORVASTATIN CALCIUM 150 121 26 11
CITALOPRAM HBR 148 77 27 27
PRAVASTATIN SODIUM 145 120 28 16
PAROXETINE HCL 142 84 29 71
RISPERIDONE 126 99 30 57
LOSARTAN POTASSIUM 126 103 30 17
CLOPIDOGREL 124 80 32 30
TRAMADOL HCL 119 105 33 19
ZOLPIDEM TARTRATE 116 82 34 24
METFORMIN HCL ER 115 93 35 67
ADVAIR DISKUS 115 83 35 48
TRAZODONE HCL 115 86 35 61
LISINOPRIL-HYDROCHLOROTHIAZIDE 112 95 38 35
NIFEDIPINE ER 103 72 39 59
ENALAPRIL MALEATE 103 92 39 31
JANUVIA 100 67 41 60
NAMENDA 100 94 41 32
IBUPROFEN 98 66 43 62
SERTRALINE HCL 95 71 44 26
DIOVAN 93 73 45 29
DIGOXIN 87 83 46 38
PLAVIX 86 71 47 43
PROAIR HFA 84 45 48 50
SPIRONOLACTONE 83 58 49 58
TAMSULOSIN HCL 82 41 50 23
NAPROXEN 80 58 51 95
PREDNISONE 73 55 52 42
DIVALPROEX SODIUM ER 73 46 52 121
METHYLPREDNISOLONE 72 62 54 144
LANTUS 70 39 55 47
MIRTAZAPINE 69 64 56 63
METOCLOPRAMIDE HCL 68 51 57 136
ALLOPURINOL 66 59 58 33
FLUOXETINE HCL 66 34 58 92
CLOTRIMAZOLE-BETAMETHASONE 66 64 58 155
NABUMETONE 66 38 58 147
GLIPIZIDE 64 53 62 44
LYRICA 64 51 62 100
FAMOTIDINE 63 48 64 36
GLYBURIDE-METFORMIN HCL 62 42 R 65 162
DICLOFENAC SODIUM 62 52 65 124
GLIMEPIRIDE 62 36 65 39
SPIRIVA 61 45 68 56
FLUTICASONE PROPIONATE 61 45 68 40
GLIPIZIDE ER 60 56 70 73
SINGULAIR 60 24 70 94
AMITRIPTYLINE HCL 59 45 R 72 91
KLOR-CON M20 59 44 72 52
CRESTOR 58 40 74 25
ISOSORBIDE MONONITRATE ER 57 30 75 49
PANTOPRAZOLE SODIUM 55 36 76 28
THEOPHYLLINE ANHYDROUS 54 41 77 253
CARBIDOPA-LEVODOPA 52 50 78 83
ZETIA 51 45 79 69
CIPROFLOXACIN HCL 51 39 79 82
AMOX TR-POTASSIUM CLAVULANATE 51 26 79 131
NOVOLOG 51 24 79 103
OXYBUTYNIN CHLORIDE 50 44 83 132
METOLAZONE 50 38 83 152
INSULIN SYRINGE 50 44 83 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 29, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.